Details

Autor(en) / Beteiligte

• Kudo, Kenichiro
• Kawakado, Keita
• Kawajiri, Tomoka
• Nishi, Tatsuya
• Makimoto, Go
• Tamura, Tomoki
• Kuyama, Shoichi
• Tanimoto, Mitsune

Titel

Dramatic Response of Brain Metastasis from EGFR-mutation-positive NSCLC to Dacomitinib

Ist Teil von

• Internal Medicine, 2020/07/15, Vol.59(14), pp.1739-1740

Ort / Verlag

Japan: The Japanese Society of Internal Medicine

Erscheinungsjahr

2020

Link zum Volltext

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• The central nervous system efficacy of dacomitinib, a key agent used in the treatment of epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC), is unclear. We herein present our experience in the use of dacomitinib for the treatment of multiple brain metastatic lesions from EGFR-mutation-positive NSCLC in an elderly patient. This case report demonstrates that dacomitinib can be an essential treatment option for patients with brain metastases.